Amgen welcomes the recent actions in Congress to ensure that patients have better access to medicines. While the legislation about to be signed into law is not perfect, it is a significant step forward for the patients we serve.
For more information about our industry position on health care reform, please refer to the press releases distributed by PhRMA and BIO – links below:
